Intuitive Surgical (ISRG) Research & Development (2009 - 2026)
Intuitive Surgical (ISRG) posted quarterly Research & Development of $370.6 million for Q2 2026, up 18.29% year-over-year from $313.3 million in Q2 2025, and up 2.4% quarter-over-quarter from $361.9 million in Q1 2026.
Intuitive Surgical (ISRG) Research & Development (2009 - 2026) Analysis & Trends
Intuitive Surgical's Research & Development history runs 18 years deep, the most recent figure standing at $370.6 million for Q2 2026.
- In Q2 2026, Research & Development rose 18.29% year-over-year to $370.6 million; the TTM figure through Jun 2026 stood at $1.4 billion (up 16.91% YoY), while the FY2025 annual figure was $1.3 billion, up 14.54% from the prior year.
- Research & Development for Q2 2026 stood at $370.6 million, up from $361.9 million in the prior quarter.
- The five-year high for Research & Development was $370.6 million in Q2 2026, with the low at $207.3 million in Q2 2022.
- The 5-year median for Research & Development is $282.3 million (2024), against an average of $281.5 million.
- The sharpest annual moves came in 2022 and 2023: Research & Development soared 33.1% in 2022, then increased 6.55% in 2023.
- Intuitive Surgical's Research & Development stood at $244.1 million in 2022, then rose by 6.55% to $260.1 million in 2023, then gained by 13.3% to $294.7 million in 2024, then grew by 19.75% to $352.9 million in 2025, then gained by 5.02% to $370.6 million in 2026.
- Business Quant data shows ISRG's Research & Development at $370.6 million in Q2 2026, $361.9 million in Q1 2026, and $352.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 370.60 Mn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 258.00 Mn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 663.00 Mn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 105.73 Mn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 19.70 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 178.00 Mn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 42.50 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 129.00 Mn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 102.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 370.60 Mn |
| Mar 31, 2026 | 361.90 Mn |
| Dec 31, 2025 | 352.90 Mn |
| Sep 30, 2025 | 329.40 Mn |
| Jun 30, 2025 | 313.30 Mn |
| Mar 31, 2025 | 316.20 Mn |
| Dec 31, 2024 | 294.70 Mn |
| Sep 30, 2024 | 286.00 Mn |
| Jun 30, 2024 | 280.10 Mn |
| Mar 31, 2024 | 284.50 Mn |
| Dec 31, 2023 | 260.10 Mn |
| Sep 30, 2023 | 249.40 Mn |
| Jun 30, 2023 | 244.40 Mn |
| Mar 31, 2023 | 244.90 Mn |
| Dec 31, 2022 | 244.10 Mn |
| Sep 30, 2022 | 217.10 Mn |
| Jun 30, 2022 | 207.30 Mn |
| Mar 31, 2022 | 210.50 Mn |
| Dec 31, 2021 | 183.40 Mn |
| Sep 30, 2021 | 165.50 Mn |